NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
Back to search
Official data from USPTO
PHYSICIAN-DIRECTED PHYSIOLOGIC INSULIN RESENSITIZATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHYSICIAN-DIRECTED PHYSIOLOGIC INSULIN RESENSITIZATION
ST13
US500000097480790Class
41
Filing
97480790
Registration
7490293
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
08/27/2024
Trademark type
Word
Nice classes
41
Filing date
06/29/2022
Registration date
08/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
08/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/05/2024
First use in commerce
06/05/2024
Drawing code
4
Owner type
16
Owner location
Houston, TX, US
Examiner
FRIEDMAN, LESLEE ANN
Law office
N20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Well Cell Global LLC
Representatives
Erik J. Osterrieder Kearney, McWilliams & Davis
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
providing health training and teaching services; providing training and teaching services on medical modalities for improving insulin resistance; providing training and teaching services on medical modality for treating diabetes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
08/27/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/24/2024
IUAA
USE AMENDMENT ACCEPTED
07/24/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
06/06/2024
IUAF
USE AMENDMENT FILED
06/06/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/06/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/06/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/18/2024
GNFR
FINAL REFUSAL E-MAILED
03/18/2024
CNFR
FINAL REFUSAL WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
02/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/26/2024
ALIE
ASSIGNED TO LIE
01/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/10/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/13/2023
GNRT
NON-FINAL ACTION E-MAILED
04/13/2023
CNRT
NON-FINAL ACTION WRITTEN
04/13/2023
DOCK
ASSIGNED TO EXAMINER
04/13/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2022
NWAP
NEW APPLICATION ENTERED
07/02/2022
Continuous trademark protection
Get notified about every new filing that threatens PHYSICIAN-DIRECTED PHYSIOLOGIC INSULIN RESENSITIZATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.